131 related articles for article (PubMed ID: 6726107)
1. Results of cyproheptadine treatment in dogs with pituitary-dependent hyperadrenocorticism.
Stolp R; Croughs RJ; Rijnberk A
J Endocrinol; 1984 Jun; 101(3):311-4. PubMed ID: 6726107
[TBL] [Abstract][Full Text] [Related]
2. Cushing syndrome in dogs: treatment with bromocriptine and cyproheptadine.
Richkind M
Vet Med Small Anim Clin; 1981 Sep; 76(9):1301-4. PubMed ID: 6277079
[No Abstract] [Full Text] [Related]
3. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs.
Peterson ME; Kintzer PP
Semin Vet Med Surg Small Anim; 1994 Aug; 9(3):127-31. PubMed ID: 7938931
[No Abstract] [Full Text] [Related]
4. Biochemical characterization of pituitary-dependent hyperadrenocorticism in the dog.
Meijer JC; de Bruijne JJ; Rijnberk A; Croughs RJ
J Endocrinol; 1978 Apr; 77(1):111-8. PubMed ID: 205621
[TBL] [Abstract][Full Text] [Related]
5. Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs.
Reusch CE; Feldman EC
J Vet Intern Med; 1991; 5(1):3-10. PubMed ID: 1850483
[TBL] [Abstract][Full Text] [Related]
6. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1996 Aug; 209(4):772-5. PubMed ID: 8756877
[TBL] [Abstract][Full Text] [Related]
7. Diurnal ACTH and plasma cortisol variations in healthy dogs and in those with pituitary-dependent Cushing's syndrome before and after treatment with retinoic acid.
Castillo VA; Cabrera Blatter MF; Gómez NV; Sinatra V; Gallelli MF; Ghersevich MC
Res Vet Sci; 2009 Apr; 86(2):223-9. PubMed ID: 18692856
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cortisol precursors for the diagnosis of pituitary-dependent hypercortisolism in dogs.
Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
Vet Rec; 2008 May; 162(21):673-8. PubMed ID: 18503066
[TBL] [Abstract][Full Text] [Related]
9. [Laboratory parameters for the control of the course of therapy of canine Cushing's syndrome].
Reusch C; Hähnle B
Tierarztl Prax; 1991 Feb; 19(1):102-6. PubMed ID: 1646492
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism.
Feldman EC
J Am Vet Med Assoc; 1983 Mar; 182(5):506-10. PubMed ID: 6300008
[No Abstract] [Full Text] [Related]
11. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism.
Neiger R; Ramsey I; O'Connor J; Hurley KJ; Mooney CT
Vet Rec; 2002 Jun; 150(26):799-804. PubMed ID: 12120922
[TBL] [Abstract][Full Text] [Related]
12. o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
Peterson ME
J Am Vet Med Assoc; 1983 Mar; 182(5):527-8. PubMed ID: 6300010
[No Abstract] [Full Text] [Related]
13. Cortisol binding capacity of corticosteroid binding globulin in hyperadrenocorticoid and healthy dogs.
Bamberg-Thalén B; Nyberg L; Fackler L; Edqvist LE
Res Vet Sci; 1992 May; 52(3):363-6. PubMed ID: 1620969
[TBL] [Abstract][Full Text] [Related]
14. Serum cortisol concentrations in dogs with pituitary-dependent hyperadrenocorticism and atypical hyperadrenocorticism.
Frank LA; Henry GA; Whittemore JC; Enders BD; Mawby DI; Rohrbach BW
J Vet Intern Med; 2015 Jan; 29(1):193-9. PubMed ID: 25411029
[TBL] [Abstract][Full Text] [Related]
15. Problems associated with medical therapy of canine hyperadrenocorticism.
Nichols R
Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
[TBL] [Abstract][Full Text] [Related]
16. Alterations in anterior pituitary function of dogs with pituitary-dependent hyperadrenocorticism.
Meij BP; Mol JA; Bevers MM; Rijnberk A
J Endocrinol; 1997 Sep; 154(3):505-12. PubMed ID: 9379128
[TBL] [Abstract][Full Text] [Related]
17. Plasma cortisol response to thyrotrophin releasing hormone and luteinizing hormone releasing hormone in healthy kennel dogs and in dogs with pituitary-dependent hyperadrenocorticism.
Stolp R; Croughs RJ; Meijer JC; Rijnberk A
J Endocrinol; 1982 Jun; 93(3):365-9. PubMed ID: 6806423
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV
J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358
[No Abstract] [Full Text] [Related]
19. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980-1990).
Kipperman BS; Feldman EC; Dybdal NO; Nelson RW
J Am Vet Med Assoc; 1992 Sep; 201(5):762-7. PubMed ID: 1328121
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS; Farver TB
J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
